Bcl10 Links Saturated Fat Overnutrition with Hepatocellular NF-κB Activation and Insulin Resistance

Cell Reports

Volumn 1, Issue 5, 2012, Pages 444-452

  Van Beek, Matthew ^a   Oravecz Wilson, Katherine I ^a   Delekta, Phillip C ^a   Gu, Shufang ^a   Li, Xiangquan ^a   Jin, Xiaohong ^a   Apel, Ingrid J ^a   Konkle, Katy S ^a   Feng, Yongjia ^a   Teitelbaum, Daniel H ^a   Ruland, Jürgen ^b,c   McAllister Lucas, Linda M ^a   Lucas, Peter C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DIACYLGLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PALMITIC ACID; PROTEIN BCL 10; PROTEIN CARMA1; PROTEIN KINASE C; PROTEIN MALT1; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME ACTIVATION; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; OVERNUTRITION; PROTECTION; PROTEIN FUNCTION; RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARCINOMA, HEPATOCELLULAR; CARD SIGNALING ADAPTOR PROTEINS; CASPASES; CELL LINE, TUMOR; CELLS, CULTURED; DIET, HIGH-FAT; FATTY ACIDS; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NEOPLASM PROTEINS; NF-KAPPA B; OVERNUTRITION; PALMITATES; RATS;

MUS;

EID: 84861692219     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.04.006     Document Type: Article

References (46)

1. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
2. Baker R.G., Hayden M.S., Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011, 13:11-22.
3. Blonska M., Lin X. NF-κB signaling pathways regulated by CARMA family of scaffold proteins. Cell Res. 2011, 21:55-70.
4. Boden G. Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 2011, 18:139-143.
5. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-kappaB. Nat. Med. 2005, 11:183-190.
6. Cousin S.P., Hügl S.R., Wrede C.E., Kajio H., Myers M.G., Rhodes C.J. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology 2001, 142:229-240.
7. Csak T., Ganz M., Pespisa J., Kodys K., Dolganiuc A., Szabo G. Fatty acids and endotoxin activate inflammasome in hepatocytes which release danger signals to activate immune cells in steatohepatitis. Hepatology 2011, 54:133-144.
8. Davis B.K., Wen H., Ting J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011, 29:707-735.
9. Deevska G.M., Nikolova-Karakashian M.N. The twists and turns of sphingolipid pathway in glucose regulation. Biochimie 2011, 93:32-38.
10. Deng Y., Johnson D.R., Guan X., Ang C.Y., Ai J., Perkins E.J. In vitro gene regulatory networks predict in vivo function of liver. BMC Syst. Biol. 2010, 4:153.
11. Erion D.M., Shulman G.I. Diacylglycerol-mediated insulin resistance. Nat. Med. 2010, 16:400-402.
12. Fessler M.B., Rudel L.L., Brown J.M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr. Opin. Lipidol. 2009, 20:379-385.
13. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29:415-445.
14. Hara H., Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol. 2009, 30:234-242.
15. Holland W.L., Summers S.A. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 2008, 29:381-402.
16. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 2001, 108:437-446.
17. Kleemann R., van Erk M., Verschuren L., van den Hoek A.M., Koek M., Wielinga P.Y., Jie A., Pellis L., Bobeldijk-Pastorova I., Kelder T., et al. Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS ONE 2010, 5:e8817.
18. Lattin J.E., Schroder K., Su A.I., Walker J.R., Zhang J., Wiltshire T., Saijo K., Glass C.K., Hume D.A., Kellie S., Sweet M.J. Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res. 2008, 4:5.
19. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276:16683-16689.
20. Liguori M.J., Blomme E.A., Waring J.F. Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells. Drug Metab. Dispos. 2008, 36:223-233.
21. McAllister-Lucas L.M., Ruland J., Siu K., Jin X., Gu S., Kim D.S., Kuffa P., Kohrt D., Mak T.W., Nuñez G., Lucas P.C. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc. Natl. Acad. Sci. USA 2007, 104:139-144.
22. Miles J.M., Nelson R.H. Contribution of triglyceride-rich lipoproteins to plasma free fatty acids. Horm. Metab. Res. 2007, 39:726-729.
23. Nakamura T., Furuhashi M., Li P., Cao H., Tuncman G., Sonenberg N., Gorgun C.Z., Hotamisligil G.S. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 2010, 140:338-348.
24. Nelson R.H., Basu R., Johnson C.M., Rizza R.A., Miles J.M. Splanchnic spillover of extracellular lipase-generated fatty acids in overweight and obese humans. Diabetes 2007, 56:2878-2884.
25. Nielsen S., Guo Z., Johnson C.M., Hensrud D.D., Jensen M.D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 2004, 113:1582-1588.
26. O'Mahony A.M., Montano M., Van Beneden K., Chen L.F., Greene W.C. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 2004, 279:18137-18145.
27. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Görgün C., Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
28. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschläger N., Schlee M., Rothenfusser S., Barchet W., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 β production. Nat. Immunol. 2010, 11:63-69.
29. Preiss S., Thompson A., Chen X., Rodgers S., Markovska V., Desmond P., Visvanathan K., Li K., Locarnini S., Revill P. Characterization of the innate immune signalling pathways in hepatocyte cell lines. J. Viral Hepat. 2008, 15:888-900.
30. Ruland J., Duncan G.S., Elia A., del Barco Barrantes I., Nguyen L., Plyte S., Millar D.G., Bouchard D., Wakeham A., Ohashi P.S., Mak T.W. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 2001, 104:33-42.
31. Ruland J., Duncan G.S., Wakeham A., Mak T.W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 2003, 19:749-758.
32. Saberi M., Woods N.B., de Luca C., Schenk S., Lu J.C., Bandyopadhyay G., Verma I.M., Olefsky J.M. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 2009, 10:419-429.
33. Sakurai H., Chiba H., Miyoshi H., Sugita T., Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 1999, 274:30353-30356.
34. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118:2992-3002.
35. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
36. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
37. Strasser D., Neumann K., Bergmann H., Marakalala M.J., Guler R., Rojowska A., Hopfner K.P., Brombacher F., Urlaub H., Baier G., et al. Syk kinase-coupled C-type lectin receptors engage protein kinase C-σ to elicit Card9 adaptor-mediated innate immunity. Immunity 2012, 36:32-42.
38. Summers S.A. Sphingolipids and insulin resistance: the five Ws. Curr. Opin. Lipidol. 2010, 21:128-135.
39. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
40. Turban S., Hajduch E. Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett. 2011, 585:269-274.
41. Unger R.H., Scherer P.E. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 2010, 21:345-352.
42. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
43. Wegener E., Krappmann D. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB. Sci. STKE 2007, 2007:pe21.
44. Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12:408-415.
45. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., Hodge C.L., Haase J., Janes J., Huss J.W., Su A.I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009, 10:R130.
46. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677.